VIR BIOTECHNOLOGY, INC. (VIR) Social Stream



VIR BIOTECHNOLOGY, INC. (VIR): $33.46

0.32 (+0.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VIR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

Vir Biotechnology Inc (VIR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Vir Biotechnology Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-21 6 $300 $36 $96.333 $33.14 190.68%
2021-11-11 5 $135 $36 $75.4 $33.14 127.52%
2021-11-30 5 $200 $36 $88.4 $33.14 166.75%
2021-11-30 6 $200 $36 $88.4 $33.14 166.75%
2021-11-05 5 $135 $37 $75.6 $33.14 128.12%

The Trend in the Analyst Price Target


Over the past 50 weeks, VIR's average price target has gone up $41.47.

Over the past 47 weeks, VIR's average upside potential has been 76.03%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-05 7 135 45 81.17 37.71 115.25%
2021-09-18 7 135 29 69.86 54.54 28.09%
2021-02-06 3 125 54 74.40 66.72 11.51%
2021-07-10 7 135 45 81.17 39.01 108.07%
2021-11-30 5 200 36 88.40 47.42 86.42%

VIR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 4 0 1 1 1 6

The Trend in the Broker Recommendations


Over the past 61 days, VIR's average broker recommendation rating improved by 0.14.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Vir Biotechnology Inc's variance in analysts' estimates is lower than -394.39% of them.
  • VIR has a higher upside potential (average analyst target price relative to current price) than 438.54% of stocks in the mid market cap category.
  • In the context of Pharmaceutical Products stocks, Vir Biotechnology Inc's average analyst price target is higher than 418.93% of them.
  • In the context of stocks in the mid market cap category, Vir Biotechnology Inc's number of analysts covering the stock is higher than 153.05% of them.

Stocks similar to Vir Biotechnology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VCEL, TIL, and SWTX.

Is VIR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7064 seconds.